Pharsight

Children's Zyrtec Hives Relief patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6455533 J AND J CONSUMER INC Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
Jul, 2018

(5 years ago)

Children'S Zyrtec Hives Relief is owned by J And J Consumer Inc.

Children'S Zyrtec Hives Relief contains Cetirizine Hydrochloride.

Children'S Zyrtec Hives Relief has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Children'S Zyrtec Hives Relief are:

  • US6455533

Children'S Zyrtec Hives Relief was authorised for market use on 30 November, 2020.

Children'S Zyrtec Hives Relief is available in tablet, chewable;oral dosage forms.

Children'S Zyrtec Hives Relief can be used as treatment of seasonal and perennial allergic rhinitis symptoms.

The generics of Children'S Zyrtec Hives Relief are possible to be released after 02 July, 2018.

Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient

Market Authorisation Date: 30 November, 2020

Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms

Dosage: TABLET, CHEWABLE;ORAL

How can I launch a generic of CHILDREN'S ZYRTEC HIVES RELIEF before it's drug patent expiration?
More Information on Dosage

CHILDREN'S ZYRTEC HIVES RELIEF family patents

Family Patents